Webinar Overview
How do you choose the best hit finding approaches? Hit Identification (Hit ID) is an evolving, multifaceted landscape, and the foundation of a successful drug discovery program. Failing to match your research ambitions and project parameters with the most suitable hit finding approach can produce a suboptimal starting lead candidate pool, increased complications, and decreased efficacy downstream. With only one in ten clinical candidates succeeding in clinical trials and regulatory approval, it is crucial to give yourself the best start possible.
In this webinar, we will examine the criteria that influence how different hit finding approaches align with your drug discovery ambitions, and the decision-making behind successful Hit ID study selection. We will also discuss how to work with a CRO to ensure Hit ID study selection truly and fully supports the direction of your research.
Register today to deepen your understanding of the Hit ID study selection process and have your questions answered by industry experts.
View this webinar to learn:
- How to apply research goals and project criteria to Hit ID study selection
- How to understand the scope of criteria that influence study suitability and selection
- How a CRO might interpret your ambitions to make more tailored hit finding recommendations
- How to work with a CRO to drive impactful Hit ID selection decisions based on your unique goals, planned research direction, circumstances and challenges
Webinar Presenters
Rob Howes, PhD, FRSB
Head of Discovery Sciences, UK
Charles River
Roger Clark, BSc (Hons)
Director, Discovery Sciences, UK
Charles River